Editorial & Opinion
Surrogate Markers and Clinical Outcomes-Reply.
العنوان: | Surrogate Markers and Clinical Outcomes-Reply. |
---|---|
المؤلفون: | Wallach JD; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia., Ramachandran R; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Ross JS; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Deputy Editor, JAMA. |
المصدر: | JAMA [JAMA] 2024 Sep 17; Vol. 332 (11), pp. 936-937. |
نوع المنشور: | Letter |
اللغة: | English |
بيانات الدورية: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Chicago : American Medical Association, 1960- |
مواضيع طبية MeSH: | Gout*/blood , Gout*/diagnosis , Gout*/drug therapy , Uric Acid*/blood, Humans ; Biomarkers/blood ; Chronic Disease/drug therapy ; Gout Suppressants/therapeutic use ; Treatment Outcome |
المشرفين على المادة: | 0 (Biomarkers) 0 (Gout Suppressants) 268B43MJ25 (Uric Acid) |
تواريخ الأحداث: | Date Created: 20240821 Date Completed: 20240917 Latest Revision: 20240918 |
رمز التحديث: | 20240919 |
DOI: | 10.1001/jama.2024.14279 |
PMID: | 39167385 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1538-3598 |
---|---|
DOI: | 10.1001/jama.2024.14279 |